Oncology

Therapeutics, diagnostics and evidence shaping cancer care.

Nanomaterials and Redox Imbalance in Cancer Therapy

A cancer nanomedicine review examines how nanomaterials may amplify redox stress, disable antioxidant defenses, and help overcome treatment resistance.

By Dr. Revathy Mohan V.R., MBBS · Oct 27, 2026 · 5 min read

Oncology·Lancet Onc

SERENA-6 shows sustained PFS benefit in biomarker-guided surveillance

Extended SERENA-6 results showed sustained progression-free survival benefit, advancing the case for biomarker-guided surveillance in oncology care.

Oct 27, 2026

Oncology·Lancet Onc

Bladder Cancer Biomarkers for Personalizing BCG Therapy Remain Unvalidated

Molecular subtyping and biomarker signals may help tailor BCG therapy in non-muscle-invasive bladder cancer, but none are validated…

Oct 27, 2026

Oncology·Lancet Onc

Lancet Oncology correction updates IMPORT LOW 10-year breast radiotherapy outcomes

Lancet Oncology corrected 10-year IMPORT LOW data, revising contralateral cancers, second primaries, angiosarcomas, and breast cancer-free interval results.

Oct 27, 2026

Oncology·NEJM

AI review refines SMO inhibitor candidacy in SHH medulloblastoma

A molecularly discordant SHH medulloblastoma case shows how AI can reconcile pathology, methylation, and sequencing when SMO inhibitor…

Oct 27, 2026

Oncology·Lancet Onc

Nanomaterial-Enhanced Immunotherapy for Bladder Cancer Gains Precision

A 2025 review examines how nanomaterials may improve T-cell immunotherapy in bladder cancer by overcoming immune suppression and…

Oct 27, 2026

Oncology·Lancet Onc

Childhood Cancer Survivors Need Better Genetic Risk Referral Pathways

A Lancet Oncology policy review explains why childhood cancer survivors with possible predisposition syndromes need clearer referral for…

Oct 27, 2026

Oncology·Lancet Onc

Lancet Oncology endometrial carcinoma guideline appendix corrected

Lancet Oncology issued a correction to the appendix of its 2025 ESGO–ESTRO–ESP endometrial carcinoma guideline update.

Oct 27, 2026

Oncology·Nature

Breast cancer asymmetry analysis gains traction in mammography modeling

Fourier multiscale analysis of mammographic asymmetry was associated with breast cancer in a matched case-control study of 368…

Oct 27, 2026

Oncology·Lancet Onc

Aesthetic Flat Closure After Mastectomy Shapes Decision-Making in Young Survivors

Young breast cancer survivors who chose aesthetic flat closure described autonomy, faster recovery, and repeated advocacy needs in…

Oct 27, 2026

Oncology

Therapeutics, diagnostics and evidence shaping cancer care.

In Brief The 5-minute rounds

New hypertension guideline lowers the treatment threshold to 130/80 mm Hg.
Phase 3 GLP-1 trial reports a 20% cut in major adverse cardiac events.
FDA clears a next-generation CAR-T therapy for relapsed lymphoma.
Meta-analysis links early mobilisation to shorter ICU length of stay.
Rapid guidance broadens empiric antibiotics for suspected sepsis.